U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hemeralopia

MedGen UID:
42391
Concept ID:
C0018975
Disease or Syndrome
Synonyms: Blindness, Day; Day Blindness; Hemeralopias
SNOMED CT: Day blindness (399323001); Hemeralopia (399323001)
 
HPO: HP:0012047

Definition

A visual defect characterized by the inability to see as clearly in bright light as in dim light. The word hemeralopia literally means day blindness. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVHemeralopia

Conditions with this feature

Enhanced S-cone syndrome
MedGen UID:
341446
Concept ID:
C1849394
Disease or Syndrome
An autosomal recessive retinopathy in which patients have increased sensitivity to blue light; perception of blue light is mediated by what is normally the least populous cone photoreceptor subtype, the S (short wavelength, blue) cones. Characteristics include visual loss, with night blindness occurring from early in life, varying degrees of L (long, red)- and M (middle, green)-cone vision, and retinal degeneration.
Congenital stationary night blindness 1B
MedGen UID:
342484
Concept ID:
C1850362
Disease or Syndrome
Autosomal recessive congenital stationary night blindness is a disorder of the retina, which is the specialized tissue at the back of the eye that detects light and color. People with this condition typically have difficulty seeing and distinguishing objects in low light (night blindness). For example, they may not be able to identify road signs at night or see stars in the night sky. They also often have other vision problems, including loss of sharpness (reduced acuity), nearsightedness (myopia), involuntary movements of the eyes (nystagmus), and eyes that do not look in the same direction (strabismus).\n\nThe vision problems associated with this condition are congenital, which means they are present from birth. They tend to remain stable (stationary) over time.
Achromatopsia 2
MedGen UID:
387867
Concept ID:
C1857618
Disease or Syndrome
Achromatopsia is characterized by reduced visual acuity, pendular nystagmus, increased sensitivity to light (photophobia), a small central scotoma, eccentric fixation, and reduced or complete loss of color discrimination. All individuals with achromatopsia (achromats) have impaired color discrimination along all three axes of color vision corresponding to the three cone classes: the protan or long-wavelength-sensitive cone axis (red), the deutan or middle-wavelength-sensitive cone axis (green), and the tritan or short-wavelength-sensitive cone axis (blue). Most individuals have complete achromatopsia, with total lack of function of all three types of cones. Rarely, individuals have incomplete achromatopsia, in which one or more cone types may be partially functioning. The manifestations are similar to those of individuals with complete achromatopsia, but generally less severe. Hyperopia is common in achromatopsia. Nystagmus develops during the first few weeks after birth followed by increased sensitivity to bright light. Best visual acuity varies with severity of the disease; it is 20/200 or less in complete achromatopsia and may be as high as 20/80 in incomplete achromatopsia. Visual acuity is usually stable over time; both nystagmus and sensitivity to bright light may improve slightly. Although the fundus is usually normal, macular changes (which may show early signs of progression) and vessel narrowing may be present in some affected individuals. Defects in the macula are visible on optical coherence tomography.
Cone-rod dystrophy 6
MedGen UID:
400963
Concept ID:
C1866293
Disease or Syndrome
The first signs and symptoms of cone-rod dystrophy, which often occur in childhood, are usually decreased sharpness of vision (visual acuity) and increased sensitivity to light (photophobia). These features are typically followed by impaired color vision (dyschromatopsia), blind spots (scotomas) in the center of the visual field, and partial side (peripheral) vision loss. Over time, affected individuals develop night blindness and a worsening of their peripheral vision, which can limit independent mobility. Decreasing visual acuity makes reading increasingly difficult and most affected individuals are legally blind by mid-adulthood. As the condition progresses, individuals may develop involuntary eye movements (nystagmus).\n\nThere are more than 30 types of cone-rod dystrophy, which are distinguished by their genetic cause and their pattern of inheritance: autosomal recessive, autosomal dominant, and X-linked. Additionally, cone-rod dystrophy can occur alone without any other signs and symptoms or it can occur as part of a syndrome that affects multiple parts of the body.\n\nCone-rod dystrophy is a group of related eye disorders that causes vision loss, which becomes more severe over time. These disorders affect the retina, which is the layer of light-sensitive tissue at the back of the eye. In people with cone-rod dystrophy, vision loss occurs as the light-sensing cells of the retina gradually deteriorate.
Leber congenital amaurosis 15
MedGen UID:
462556
Concept ID:
C3151206
Disease or Syndrome
Autosomal recessive childhood-onset severe retinal dystrophy is a heterogeneous group of disorders affecting rod and cone photoreceptors simultaneously. The most severe cases are termed Leber congenital amaurosis, whereas the less aggressive forms are usually considered juvenile retinitis pigmentosa (summary by Gu et al., 1997). Mutation in TULP1 can also cause a form of autosomal recessive retinitis pigmentosa (RP14; 600132). For a general phenotypic description and a discussion of the genetic heterogeneity of Leber congenital amaurosis, see LCA1 (204000); for retinitis pigmentosa, see 268000.
Congenital stationary night blindness 1A
MedGen UID:
501208
Concept ID:
C3495587
Disease or Syndrome
X-linked congenital stationary night blindness (CSNB) is characterized by non-progressive retinal findings of reduced visual acuity ranging from 20/30 to 20/200; defective dark adaptation; refractive error, most typically myopia ranging from low (-0.25 diopters [D] to -4.75 D) to high (=-10.00 D) but occasionally hyperopia; nystagmus; strabismus; normal color vision; and normal fundus examination. Characteristic ERG findings can help distinguish between complete X-linked CSNB and incomplete X-linked CSNB.
Bardet-Biedl syndrome 20
MedGen UID:
934674
Concept ID:
C4310707
Disease or Syndrome
Bardet-Biedl syndrome-20 (BBS20), a rare autosomal recessive disorder associated with ciliary dysfunction, is characterized by rod-cone dystrophy, postaxial polydactyly, truncal obesity, renal anomalies, and learning disability, as well as hypogonadism in males and genital abnormalities in females (Saida et al., 2014). For a general phenotypic description and discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900).
Cone-rod dystrophy and hearing loss 1
MedGen UID:
1682048
Concept ID:
C5193018
Disease or Syndrome
CRDHL1 is characterized by cone-rod dystrophy and sensorineural hearing loss, with relatively late onset of both ocular and hearing impairment. The funduscopic findings are characteristic, showing ring-shaped atrophy along the major vascular arcades that manifests on fundus autofluorescence as a hypoautofluorescent band along the vascular arcades surrounded by hyperautofluorescent borders (Namburi et al., 2016). Genetic Heterogeneity of Cone-Rod Dystrophy and Hearing Loss CRDHL2 (618358) is caused by mutation in the CEP250 gene (609689) on chromosome 20q11.

Professional guidelines

PubMed

Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, Marinò M, Vaidya B, Wiersinga WM; EUGOGO †
Eur J Endocrinol 2021 Aug 27;185(4):G43-G67. doi: 10.1530/EJE-21-0479. PMID: 34297684
Raoof N, Hoffmann J
Cephalalgia 2021 Apr;41(4):472-478. Epub 2021 Feb 25 doi: 10.1177/0333102421997093. PMID: 33631966Free PMC Article
Stein JD, Khawaja AP, Weizer JS
JAMA 2021 Jan 12;325(2):164-174. doi: 10.1001/jama.2020.21899. PMID: 33433580

Recent clinical studies

Etiology

Sather R 3rd, Ihinger J, Simmons M, Khundkar T, Lobo GP, Montezuma SR
Int J Mol Sci 2023 Jun 30;24(13) doi: 10.3390/ijms241310895. PMID: 37446072Free PMC Article
Angée C, Nedelec B, Erjavec E, Rozet JM, Fares Taie L
Genes (Basel) 2021 Apr 22;12(5) doi: 10.3390/genes12050624. PMID: 33922078Free PMC Article
Tsang SH, Sharma T
Adv Exp Med Biol 2018;1085:53-60. doi: 10.1007/978-3-319-95046-4_12. PMID: 30578485
Gotovac M, Kastelan S, Lukenda A
Coll Antropol 2013 Apr;37 Suppl 1:189-93. PMID: 23837242
Khan AO, Abu-Safieh L, Eisenberger T, Bolz HJ, Alkuraya FS
Br J Ophthalmol 2013 Jun;97(6):760-4. Epub 2013 Mar 16 doi: 10.1136/bjophthalmol-2012-303050. PMID: 23505306

Diagnosis

Sather R 3rd, Ihinger J, Simmons M, Khundkar T, Lobo GP, Montezuma SR
Int J Mol Sci 2023 Jun 30;24(13) doi: 10.3390/ijms241310895. PMID: 37446072Free PMC Article
Mittal K, Chawla R
Ophthalmic Surg Lasers Imaging Retina 2016 Nov 1;47(11):1068. doi: 10.3928/23258160-20161031-14. PMID: 27842204
Vaphiades MS, Doyle JI
J Neuroophthalmol 2014 Dec;34(4):366-8. doi: 10.1097/WNO.0000000000000119. PMID: 24705257
Gotovac M, Kastelan S, Lukenda A
Coll Antropol 2013 Apr;37 Suppl 1:189-93. PMID: 23837242
Miller RC, Tewari A, Miller JA, Garbern J, Van Stavern GP
J Neuroophthalmol 2009 Sep;29(3):180-6. doi: 10.1097/WNO.0b013e3181b1b3f8. PMID: 19726938

Therapy

Cheng Z, Purcell W, Ghadiri N, Tan SZ, Madhusudhan S
Digit J Ophthalmol 2023;29(2):50-57. Epub 2023 May 7 doi: 10.5693/djo.02.2023.01.004. PMID: 37727465Free PMC Article
Horiguchi H, Suzuki E, Kubo H, Fujikado T, Asonuma S, Fujimoto C, Tatsumoto M, Fukuchi T, Sakaue Y, Ichimura M, Kurimoto Y, Yamamoto M, Nakadomari S
Jpn J Ophthalmol 2021 May;65(3):432-438. Epub 2021 Jan 9 doi: 10.1007/s10384-020-00808-2. PMID: 33420857
Gotovac M, Kastelan S, Lukenda A
Coll Antropol 2013 Apr;37 Suppl 1:189-93. PMID: 23837242
Boccardo F, Decensi AU, Guarneri D, Martorana G, Fioretto L, Mini E, Macaluso MP, Giuliani L, Santi L, Periti P
Cancer Detect Prev 1991;15(6):501-3. PMID: 1782640

Prognosis

Miller RC, Tewari A, Miller JA, Garbern J, Van Stavern GP
J Neuroophthalmol 2009 Sep;29(3):180-6. doi: 10.1097/WNO.0b013e3181b1b3f8. PMID: 19726938
Zouboulis CC
Eur J Dermatol 2002 Sep-Oct;12(5):471-4. PMID: 12370138
Edwards AO, Miedziak A, Vrabec T, Verhoeven J, Acott TS, Weleber RG, Donoso LA
Am J Ophthalmol 1999 Apr;127(4):426-35. doi: 10.1016/s0002-9394(98)00331-6. PMID: 10218695
Grøndahl J, Mjøen S
Clin Genet 1986 Jul;30(1):14-28. doi: 10.1111/j.1399-0004.1986.tb00564.x. PMID: 3757293
Jaeger W, Götz ML
Ophthalmic Paediatr Genet 1985 Feb;5(1-2):19-23. doi: 10.3109/13816818509007851. PMID: 4058867

Clinical prediction guides

Smirnov VM, Zeitz C, Soumittra N, Audo I, Defoort-Dhellemmes S
Doc Ophthalmol 2018 Apr;136(2):135-143. Epub 2018 Mar 10 doi: 10.1007/s10633-018-9629-y. PMID: 29525873
Mittal K, Chawla R
Ophthalmic Surg Lasers Imaging Retina 2016 Nov 1;47(11):1068. doi: 10.3928/23258160-20161031-14. PMID: 27842204
Miller RC, Tewari A, Miller JA, Garbern J, Van Stavern GP
J Neuroophthalmol 2009 Sep;29(3):180-6. doi: 10.1097/WNO.0b013e3181b1b3f8. PMID: 19726938
Grøndahl J, Mjøen S
Clin Genet 1986 Jul;30(1):14-28. doi: 10.1111/j.1399-0004.1986.tb00564.x. PMID: 3757293
Korczyn AD, Ben-Tovim N
Electroencephalogr Clin Neurophysiol 1978 Dec;45(6):785-8. doi: 10.1016/0013-4694(78)90146-3. PMID: 84746

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...